TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36397215

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at back-shu points (Ganshu, Xinshu, Pishu, Feishu, Shenshu) with continuous wave, 2 Hz frequency, 20 min each time, once every other day, for 3 courses (2 weeks each).
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sham electroacupuncture at non-acupoints with shallow needling, no current, same treatment duration as EA group.
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at back-shu points (Ganshu, Xinshu, Pishu, Feishu, Shenshu).
Number of subjects: 72
Study: 32174362

Group type: EXPERIMENTAL
Intervention: N-back task (cognitive load)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surrogate Reference Task (SuRT) (visual load)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No non-driving related task (control condition)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Easy non-driving related task (cognitive load)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Difficult non-driving related task (cognitive load)
Number of subjects: 0
Study: 37936657

Group type: EXPERIMENTAL
Intervention: Watchful Waiting (WW)
Number of subjects: 496
Study: 33402259

Group type: EXPERIMENTAL
Intervention: Duloxetine (10-week treatment)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine (12-week treatment)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo (for both trials)
Number of subjects: 78
Study: 35303890

Group type: EXPERIMENTAL
Intervention: 3D-printed patient-specific instrument (PSI) based on H-point
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group with standard technique
Number of subjects: 26
Study: 32429355

Group type: EXPERIMENTAL
Intervention: Balanced protein distribution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sufficient protein quantity in at least one meal
Number of subjects: 0
Study: 34122679

Group type: EXPERIMENTAL
Intervention: Extent of visceral pleural invasion (VPI) incorporated into a prognostic nomogram
Number of subjects: 87045

Group type: EXPERIMENTAL
Intervention: Training group (n=60,933)
Number of subjects: 87045

Group type: EXPERIMENTAL
Intervention: Validation group (n=26,112)
Number of subjects: 87045

Group type: EXPERIMENTAL
Intervention: Calibration curve assessment
Number of subjects: 87045
Study: 36342382

Group type: EXPERIMENTAL
Intervention: Online educational course for medical providers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Online educational course
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medical and nursing trained intervention group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical and nursing trained control group
Number of subjects: 0
Study: 33285282

Group type: EXPERIMENTAL
Intervention: 2% alcoholic chlorhexidine
Number of subjects: 113

Group type: COMPARATOR
Intervention: 5% alcoholic povidone-iodine
Number of subjects: 113
Study: 34663704

Group type: EXPERIMENTAL
Intervention: Anodal ctDCS
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cathodal ctDCS
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham ctDCS
Number of subjects: 60
Study: 32855633

Group type: EXPERIMENTAL
Intervention: 140 Hz tACS
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 20 Hz tACS
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: tRNS
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham stimulation (1 mA)
Number of subjects: 43
Study: 34725453

Group type: EXPERIMENTAL
Intervention: AYA patients (16-30 years)
Number of subjects: 597

Group type: COMPARATOR
Intervention: Younger patients (1-15 years)
Number of subjects: 597
Study: 33783568

Group type: EXPERIMENTAL
Intervention: Plastic containers
Number of subjects: 43

Group type: COMPARATOR
Intervention: Glass containers
Number of subjects: 43
Study: 33673788

Group type: EXPERIMENTAL
Intervention: Resistance training (RT) consisting of supervised bicep curls 3 days per week for 4 weeks (5 sets of 10 repetitions at 75% of 1-repetition maximum)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (n=15)
Number of subjects: 36
Study: 32846775

Group type: EXPERIMENTAL
Intervention: Physical Therapy Exercises (PTE)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Wharton Jelly mesenchymal stem cell (WJ‐MSCs) injections
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined intervention (PTE + WJ‐MSCs)
Number of subjects: 60
Study: 36092975

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 32203712

Group type: EXPERIMENTAL
Intervention: Palivizumab (15 mg/kg, intramuscular injections during RSV season)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Palivizumab
Number of subjects: 429

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Absence of PCR-confirmed RSV infection at 1 year
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Reversible airway obstruction at 6 years
Number of subjects: 429
Study: 35803628

Group type: EXPERIMENTAL
Intervention: Luteal phase progesterone for 3 weeks
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Luteal phase progesterone for 7 weeks
Number of subjects: 1800

Group type: COMPARATOR
Intervention: No luteal phase progesterone
Number of subjects: 1800
Study: 33915368

Group type: EXPERIMENTAL
Intervention: Mindfulness Based Stress Reduction (MBSR) training
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 66
Study: 36370176

Group type: EXPERIMENTAL
Intervention: Collagen peptides (CP) 10 g·day‐1
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo control (CON)
Number of subjects: 20
Study: 33470341

Group type: EXPERIMENTAL
Intervention: 30 mg codeine and 500 mg acetaminophen (4 times a day for 4 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 32717180

Group type: EXPERIMENTAL
Intervention: Second-look surgery plus oxaliplatin-HIPEC (oxaliplatin 460 mg/m2, or oxaliplatin 300 mg/m2 plus irinotecan 200 mg/m2, plus intravenous fluorouracil 400 mg/m2)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Surveillance
Number of subjects: 150
Study: 35367245

Group type: EXPERIMENTAL
Intervention: STRIP intervention group (heart-healthy diet with low SAFAs and cholesterol, counseling at least biannually from age 7 months to 20 years)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study: 34584543

Group type: EXPERIMENTAL
Intervention: MIXTIVA infusion (remifentanil/propofol at a proportion of 2/1,000 or 3/1,000)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard TIVA with separate remifentanil and propofol infusions (Control Group I)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: MIXTIVA infusion (Group III with remifentanil concentration 30 µg/ml)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: MIXTIVA infusion (Group II with remifentanil concentration 20 µg/ml)
Number of subjects: 96
Study: 34084153

Group type: EXPERIMENTAL
Intervention: CDCA 1.25 g
Number of subjects: 20

Group type: COMPARATOR
Intervention: CDCA 1.25 g + colesevelam 3.75 g
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CDCA 1.25 g (with mixed meal)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: colesevelam 3.75 g (with mixed meal)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: colesevelam 3.75 g × 2 (with mixed meal)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No additions (with mixed meal)
Number of subjects: 20
Study: 32308366

Group type: EXPERIMENTAL
Intervention: N-butylphthalide (NBP) and dexamethasone (DXM) combined with hyperbaric oxygen (HBO) therapy
Number of subjects: 171

Group type: COMPARATOR
Intervention: HBO therapy as monotherapy (Control)
Number of subjects: 171
Study: 32197629

Group type: EXPERIMENTAL
Intervention: NEMEX-TJR twice weekly for 12 weeks combined with two sessions of PNE
Number of subjects: 120

Group type: COMPARATOR
Intervention: Two sessions of PNE given over 6 weeks
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: NEMEX-TJR and PNE
Number of subjects: 120
Study: 34649935

Group type: EXPERIMENTAL
Intervention: IV alteplase prior to MT
Number of subjects: 235

Group type: COMPARATOR
Intervention: MT-only group (no alteplase)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: IV alteplase + aspiration first MT
Number of subjects: 235

Group type: COMPARATOR
Intervention: No alteplase + aspiration first MT
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: IV alteplase + stent retriever first MT
Number of subjects: 235

Group type: COMPARATOR
Intervention: No alteplase + stent retriever first MT
Number of subjects: 235
Study: 33314283

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 116

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 116
Study: 35598187

Group type: EXPERIMENTAL
Intervention: Soap cleaning
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Soap-plus-microwave
Number of subjects: 100
Study: 33549019

Group type: EXPERIMENTAL
Intervention: PSORI-CM01 granules
Number of subjects: 63

Group type: COMPARATOR
Intervention: Yinxieling tablets
Number of subjects: 63
Study: 32229324

Group type: EXPERIMENTAL
Intervention: D-cycloserine (250 mg)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 32808147

Group type: EXPERIMENTAL
Intervention: HILT plus therapeutic exercises
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham-laser plus therapeutic exercises
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control-therapeutic exercises only
Number of subjects: 36
Study: 36028894

Group type: EXPERIMENTAL
Intervention: Digital aftercare service
Number of subjects: 150

Group type: COMPARATOR
Intervention: Regular aftercare (TAU)
Number of subjects: 150
Study: 36470906

Group type: EXPERIMENTAL
Intervention: Relaxation breathing
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Relaxation breathing combined with cardiac biofeedback
Number of subjects: 147

Group type: COMPARATOR
Intervention: Control
Number of subjects: 147
Study: 33389761

Group type: EXPERIMENTAL
Intervention: Nano-curcumin (Sinacurcumin soft gel, 40 mg curcuminoids as nanomicelles, two capsules twice a day)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 41
Study: 35938937

Group type: EXPERIMENTAL
Intervention: Extract of Dolichos biflorus seeds (1,600 mg)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Extract of Cynodon dactylon rhizome (1,600 mg)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 34362522

Group type: EXPERIMENTAL
Intervention: Astaxanthin (ASTA) at concentrations of 5, 10, and 20 μmol/L
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group A (DMSO added)
Number of subjects: 0
Study: 32902210

Group type: EXPERIMENTAL
Intervention: Delta check limits for outpatients
Number of subjects: 434927

Group type: EXPERIMENTAL
Intervention: Delta check limits for inpatients
Number of subjects: 434927

Group type: COMPARATOR
Intervention: Reference change value (RCV)
Number of subjects: 434927

Group type: EXPERIMENTAL
Intervention: Delta check procedure
Number of subjects: 434927
Study: 36178031

Group type: EXPERIMENTAL
Intervention: Videos
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Podcasts
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Texts
Number of subjects: 320
Study: 32239171

Group type: EXPERIMENTAL
Intervention: Induced blood-stage malaria (IBSM)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Mosquito bite (MB)
Number of subjects: 24
Study: 32452912

Group type: EXPERIMENTAL
Intervention: Unadjusted approach assuming data are missing-completely-at-random (MCAR)
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Stratification on baseline predictors
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Full adjustment for baseline and time-updated variables
Number of subjects: 100000
Study: 36126565

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 275

Group type: COMPARATOR
Intervention: Ticagrelor
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Clopidogrel (discontinued <3 days before surgery)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Clopidogrel (discontinued ≥3 days)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Ticagrelor (discontinued <3 days before surgery)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Ticagrelor (discontinued ≥3 days)
Number of subjects: 275
Study: 33873075

Group type: EXPERIMENTAL
Intervention: Fiasp®
Number of subjects: 67

Group type: COMPARATOR
Intervention: NovoLog®
Number of subjects: 67
Study: 32776103

Group type: EXPERIMENTAL
Intervention: 20 mg methylphenidate
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 36498603

Group type: EXPERIMENTAL
Intervention: 3D adjustable posture corrective orthotic (PCO) added to a multimodal program; performed mirror image therapy for 20–30 min while walking on a treadmill 2–3 times per week for 10 weeks.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Multimodal program without the 3D PCO.
Number of subjects: 24
Study: 32658939

Group type: EXPERIMENTAL
Intervention: Intervention group (IR, n = 40) wore face shields and hand sanitized frequently
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (CR, n = 35)
Number of subjects: 52
Study: 32950989

Group type: EXPERIMENTAL
Intervention: Nasal device (soft silicone insert) for 5-12 hours daily
Number of subjects: 156

Group type: COMPARATOR
Intervention: Normal saline drops (control group)
Number of subjects: 156
Study: 32248698

Group type: EXPERIMENTAL
Intervention: Interactive web training (IWT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study: 33213471

Group type: EXPERIMENTAL
Intervention: Plasmodium vivax infection
Number of subjects: 4200

Group type: EXPERIMENTAL
Intervention: Plasmodium falciparum infection
Number of subjects: 4200

Group type: EXPERIMENTAL
Intervention: Recent travels to forest sites
Number of subjects: 4200

Group type: EXPERIMENTAL
Intervention: Forest work
Number of subjects: 4200

Group type: EXPERIMENTAL
Intervention: Residing in villages at the forest fringe or inside the forest
Number of subjects: 4200

Group type: EXPERIMENTAL
Intervention: Village-level differences in prevalence
Number of subjects: 4200

Group type: EXPERIMENTAL
Intervention: Spatial hotspots of infection in villages inside the forest
Number of subjects: 4200
Study: 34021326

Group type: EXPERIMENTAL
Intervention: Surgical cognitive simulation (SCS) training
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no SCS training)
Number of subjects: 21
Study: 36289500

Group type: EXPERIMENTAL
Intervention: MIS bone graft delivery device
Number of subjects: 73

Group type: COMPARATOR
Intervention: Conventional system
Number of subjects: 73
Study: 34714112

Group type: EXPERIMENTAL
Intervention: PRC-063 (all doses combined; 25, 45, 70, or 85 mg/day)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: PRC-063 (all doses combined)
Number of subjects: 367

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: OLE study (PRC-063)
Number of subjects: 367
Study: 32432481

Group type: EXPERIMENTAL
Intervention: Radial head arthroplasty
Number of subjects: 152

Group type: COMPARATOR
Intervention: Radial head fracture fixation
Number of subjects: 152
Study: 32244696

Group type: EXPERIMENTAL
Intervention: One meal replacement
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Two meal replacements
Number of subjects: 112

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 112
Study: 36653409

Group type: EXPERIMENTAL
Intervention: Caffeine (150 mg × 3 times/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Withdrawal condition (9-day caffeine followed by 1-day placebo)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (3 times/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 20
Study: 34360105

Group type: EXPERIMENTAL
Intervention: Handful
Number of subjects: 120

Group type: COMPARATOR
Intervention: 30 g serving
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Usual serving
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Large handful
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Small handful
Number of subjects: 120
Study: 32481334

Group type: EXPERIMENTAL
Intervention: Fire needle therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Watchful waiting with lifestyle advice and education regarding BPH
Number of subjects: 60
Study: 34742096

Group type: EXPERIMENTAL
Intervention: Baduanjin exercise
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (health education sessions)
Number of subjects: 48
Study: 33834343

Group type: EXPERIMENTAL
Intervention: Tomato cultivars with 3.6 mg kg‐1 Cd
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Tomato cultivars with 12 mg kg‐1 Cd
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Tomato cultivars with long-term exposure to 12 mg kg‐1 Cd
Number of subjects: 3
Study: 35000893

Group type: EXPERIMENTAL
Intervention: Experimental formula (EF) with higher protein level of 3.4 g/100 kcal and improved fat blend
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control formula (CF) with protein level of 2.9 g/100 kcal and standard fat blend
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Experimental formula (EF)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Experimental formula (EF) and Control formula (CF)
Number of subjects: 160
Study: 33116455

Group type: EXPERIMENTAL
Intervention: Icenticaftor 300 mg b.i.d.
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 33734369

Group type: EXPERIMENTAL
Intervention: Freeze-all strategy (IVF with frozen-thawed blastocyst transfer)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Conventional strategy (IVF with fresh and frozen-thawed blastocyst transfer)
Number of subjects: 205
Study: 35716932

Group type: EXPERIMENTAL
Intervention: Low-dose colchicine
Number of subjects: 429

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 429
Study: 33454896

Group type: EXPERIMENTAL
Intervention: CART analysis model
Number of subjects: 151

Group type: COMPARATOR
Intervention: Conventional Cox model
Number of subjects: 151
Study: 32005992

Group type: EXPERIMENTAL
Intervention: Immediate iron treatment (ferrous sulfate 2 mg · kg‐1 · d‐1 for 3 months)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Delayed iron treatment (ferrous sulfate 2 mg · kg‐1 · d‐1 for 3 months, starting 28 days after antimalarial treatment)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Asymptomatic community children (comparison group)
Number of subjects: 239
Study: 33655794

Group type: EXPERIMENTAL
Intervention: Integrated diabetes self-management program using smartphone application
Number of subjects: 68
Study: 33713411

Group type: EXPERIMENTAL
Intervention: Yellow warnings (YB)
Number of subjects: 1131

Group type: EXPERIMENTAL
Intervention: White on black warnings (WB)
Number of subjects: 1131

Group type: COMPARATOR
Intervention: Black on white warnings (BW)
Number of subjects: 1131
Study: 32705319

Group type: EXPERIMENTAL
Intervention: Peri-articular infiltration of morphine, ropivacaine, and epinephrine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with peri-articular infiltration of ropivacaine and epinephrine only
Number of subjects: 0
Study: 36042753

Group type: EXPERIMENTAL
Intervention: Thymosin α1 (Tα1)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 32855225

Group type: EXPERIMENTAL
Intervention: Tobramycin inhalation powder (TIP) - 84 mg (3 capsules once daily)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Tobramycin inhalation powder (TIP) - 140 mg (5 capsules once daily)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Tobramycin inhalation powder (TIP) - 224 mg (4 capsules twice daily)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Continuous TIP
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Cyclical TIP
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Overall TIP (all doses)
Number of subjects: 107
Study: 35238960

Group type: EXPERIMENTAL
Intervention: Ivabradine 5 mg twice daily for 3 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-ivabradine group
Number of subjects: 60
Study: 32047925

Group type: EXPERIMENTAL
Intervention: Legume supplementation (cowpea or common bean)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Cowpea or common bean supplementation
Number of subjects: 236
Study: 33191588

Group type: EXPERIMENTAL
Intervention: Cetuximab plus irinotecan
Number of subjects: 452

Group type: COMPARATOR
Intervention: Irinotecan
Number of subjects: 452
Study: 32049551

Group type: EXPERIMENTAL
Intervention: Spanish version of the HPV Impact Profile scale (HIP)
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Multigroup analysis according to women's age
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Confirmatory analysis of the HIP
Number of subjects: 675
Study: 35403228

Group type: EXPERIMENTAL
Intervention: E-learning assisted practice after theoretical lesson on cariology
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: E-learning assisted practice
Number of subjects: 53
Study: 32239311

Group type: EXPERIMENTAL
Intervention: Traditional Strength Training (TST) + High-Intensity Interval Training (HIIT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Power Training (PT) + High-Intensity Interval Training (HIIT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both TST and PT
Number of subjects: 35
Study: 34949972

Group type: EXPERIMENTAL
Intervention: Intelligent heating box
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 200
Study: 34031056

Group type: EXPERIMENTAL
Intervention: Afatinib (40 mg orally once daily)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Afatinib + Cetuximab (Cetuximab 250 mg/m² on day 15 of cycle 1, then every 2 weeks at 500 mg/m² for 6 months)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Both groups (Afatinib vs Afatinib + Cetuximab)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Afatinib + Cetuximab
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: EGFR gene mutation allele frequency in circulating tumor DNA
Number of subjects: 117
Study: 34289052

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 32807092

Group type: EXPERIMENTAL
Intervention: Short-duration antibiotic therapy (7 days) after catheter removal
Number of subjects: 185

Group type: COMPARATOR
Intervention: Long-duration antibiotic therapy (≥14 days)
Number of subjects: 185